The effect of press-needle therapy on postoperative nausea and vomiting in patients undergoing bronchoscopy under general anesthesia in China: a quasi-experimental study - Scorecard - MDSpire
Advertisement
The effect of press-needle therapy on postoperative nausea and vomiting in patients undergoing bronchoscopy under general anesthesia in China: a quasi-experimental study
Clinical Scorecard: Impact of Press-Needle Therapy on Postoperative Nausea and Vomiting in Patients Receiving General Anesthesia for Bronchoscopy in China: A Quasi-Experimental Investigation
At a Glance
Category
Detail
Condition
Postoperative Nausea and Vomiting (PONV)
Key Mechanisms
Press-needle therapy at acupoints PC6, LI4, ST36 for nausea and vomiting prevention.
Target Population
Patients undergoing bronchoscopy under general anesthesia, aged 18-70.
Care Setting
Henan Provincial Chest Hospital, China.
Key Highlights
Non-pharmacologic PONV prevention via press-needle therapy.
Significantly reduced nausea and vomiting incidence post-bronchoscopy.
Lowered rescue antiemetic use in the press-needle group.
Minimal impact on vital signs, indicating safety as an adjunctive intervention.
First quasi-experimental evidence for this therapy in GA bronchoscopy patients.
Guideline-Based Recommendations
Diagnosis
Assess for PONV risk factors prior to bronchoscopy.
Management
Consider press-needle therapy as a non-pharmacologic option for PONV prevention.
Monitoring & Follow-up
Monitor nausea/vomiting rates and severity at 0-6, 6-24, and 24-48 hours post-op.
Risks
Potential for dehydration, electrolyte imbalances, and pulmonary aspiration due to PONV.
Patient & Prescribing Data
Elective bronchoscopy patients under general anesthesia.
Press-needle therapy significantly reduces PONV rates and severity.
Clinical Best Practices
Implement press-needle therapy 30 minutes prior to anesthesia.
“And when one of these measles cases ends up in a low-immunization community, that's when the ember really has a chance to expand and become a wildfire.”
